Tokyo, July 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058636) titled 'A Study on the Clinical Psychological Characteristics of "Pseudo-ADHD"' on July 29.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Kwansei Gakuin University
Condition:
Condition - Attention Deficit/Hyperactivity Disorder
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The applicant newly defines a group of individuals who did not exhibit ADHD symptoms during childhood but first became aware of such symptoms in adulthood as Pseudo-ADHD and is currently investigating their clinical psychological characteristics. In the present study, an exploratory examination will be conducted to assess how factors such as fear of COVID-19, current interpersonal stress events, coping strategies, social functioning, and occupational stress influence the manifestation of Pseudo-ADHD. These data will serve as theoretical support for the effectiveness of interpersonal counseling in addressing depressive states following the resolution of the COVID-19 pandemic.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Individuals who are able to provide informed consent to participate in a survey conducted via a crowdsourcing service (Lancers: https://www.lancers.jp/help/terms).
Key exclusion criteria - None
Target Size - 1000
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 06 Month 19 Day
Date of IRB - 2025 Year 06 Month 19 Day
Anticipated trial start date - 2025 Year 06 Month 19 Day
Last follow-up date - 2025 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067054
Disclaimer: Curated by HT Syndication.
